CannLabs Inc (CANL)
0.00
USD |
OTCM |
May 22, 16:00
CannLabs Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2015 | 3.716 |
| December 31, 2014 | 1606.08 |
| September 30, 2014 | 2.934 |
| June 30, 2014 | 0.5361 |
| March 31, 2014 | 0.0824 |
| December 31, 2013 | 500.00 |
| September 30, 2013 | 0.0579 |
| June 30, 2013 | 0.0543 |
| March 31, 2013 | 6.798 |
| December 31, 2012 | 5.469 |
| September 30, 2012 | -0.3244 |
| Date | Value |
|---|---|
| June 30, 2012 | 0.3502 |
| March 31, 2012 | 4.753 |
| December 31, 2011 | 0.2909 |
| September 30, 2011 | 0.4036 |
| June 30, 2011 | 1.495 |
| March 31, 2011 | 0.491 |
| December 31, 2010 | 0.1417 |
| September 30, 2010 | 13.85 |
| June 30, 2010 | |
| March 31, 2010 | |
| December 31, 2009 | 1.015 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| AIM ImmunoTech Inc | 0.5332 |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 0.6856 |
| Electromed Inc | 0.00 |
| Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.126M |
| Total Liabilities (Quarterly) | 0.6322M |
| Shareholders Equity (Quarterly) | 0.4935M |